Skip to content

Allphase Pharma Consulting, LLC

A Professional Service Provider for the Pharma Industry

Allphase Pharma Consulting, LLC
Menu

Primary menu

  • CONTACT
  • BLOGS
    • The Viewpoint
    • The News
    • Recent Literature
    • Did you know…?
    • QIDP Antibiotics
  • LEGAL
  • WELCOME

Secondary menu

  • The News
  • The Viewpoint
  • Did you know…?
  • Recent Literature
  • QIDP Antibiotics

Tag Archives: development of MDR-pathogen antibiotics

Artie’s Law: Avoid Bad Advice and Don’t Follow ‘Mission Impossible’ Advice

Posted on April 8, 2015 by Harald — No Comments ↓

In this day and age, few truly broad spectrum antibiotics are in development, although this does not hold true for narrow-spectrums.  Just think of all the MRSA drugs (quinolones, FabI inhibitors), the pseudomonas drugs (NCEs and monoclonals) or some narrow spectrum drugs that will need to be tested in MDR Continue reading Artie’s Law: Avoid Bad Advice and Don’t Follow ‘Mission Impossible’ Advice→

Share this:

  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to print (Opens in new window) Print
  • Click to email a link to a friend (Opens in new window) Email
  • Click to share on WhatsApp (Opens in new window) WhatsApp

Like this:

Like Loading...
Posted in The Viewpoint | Tagged Achaogen, Advanced Life Sciences, ALS, antibiotic blog, Artie’s law, carbapenem-resistance, Cethromycin, colistin, CRE, development of MDR-pathogen antibiotics, development of narrow spectrum antibiotics, erythromycin, FabI inhibitor, FDA Guidance, J&J, ketolide, Lasagna’s law, LpxC inhibitors, MDR pathogens, MDR S. pneumonia, monoclonal antibodies, MRSA, Muench’s Third law, ofloxacin, Ortho, plazomicin, POL7080, pseudomonas, quinolones, Restanza | Leave a reply

Go back

Your message has been sent

Rating(required)
Warning

Footer Menu

Footer menu

  • CONTACT
  • BLOGS
  • LEGAL
  • WELCOME
  • Email
Copyright © 2026 Allphase Pharma Consulting, LLC. All Rights Reserved.
Theme: Catch Box by Catch Themes
Scroll Up
%d